| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $399,250 | 1 | 100 |
| Morrell Martha | CHIEF MEDICAL OFFICER | 0 | $0 | 1 | $399,250 | $-399,250 |
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for …
Over the last 12 months, insiders at NeuroPace, Inc. have bought $0 and sold $399,250 worth of NeuroPace, Inc. stock.
On average, over the past 5 years, insiders at NeuroPace, Inc. have bought $585,046 and sold $13.06M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 62,398 shares for transaction amount of $93,535 was made by Accelmed Partners II L.P. (director) on 2022‑11‑22.
| 2025-12-15 | Sale | Morrell Martha | CHIEF MEDICAL OFFICER | 25,000 0.0753% | $15.97 | $399,250 | -5.56% | |
| 2025-05-14 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 168,136 0.5216% | $15.85 | $2.67M | -14.23% | |
| 2025-02-21 | Sale | Morrell Martha | CHIEF MEDICAL OFFICER | 78,334 0.2531% | $13.72 | $1.07M | -15.50% | |
| 2025-02-20 | Sale | KCK LTD. | 10 percent owner | 5.27M 12.3415% | $9.40 | $49.55M | -18.20% | |
| 2025-01-30 | Sale | Morrell Martha | CHIEF MEDICAL OFFICER | 200 0.0007% | $15.00 | $3,000 | -17.97% | |
| 2025-01-29 | Sale | Morrell Martha | CHIEF MEDICAL OFFICER | 100 0.0004% | $15.00 | $1,500 | -20.76% | |
| 2025-01-24 | Sale | Morrell Martha | CHIEF MEDICAL OFFICER | 3,200 0.0109% | $15.01 | $48,032 | -20.80% | |
| 2024-10-25 | Sale | KCK LTD. | 10 percent owner | 223,991 0.697% | $5.45 | $1.22M | +71.81% | |
| 2024-10-23 | Sale | KCK LTD. | 10 percent owner | 147 0.0005% | $6.02 | $885 | +84.58% | |
| 2024-10-22 | Sale | KCK LTD. | 10 percent owner | 4,082 0.0142% | $6.09 | $24,853 | +81.50% | |
| 2024-10-21 | Sale | KCK LTD. | 10 percent owner | 3,720 0.0125% | $6.10 | $22,679 | +75.65% | |
| 2024-10-18 | Sale | KCK LTD. | 10 percent owner | 4,878 0.0162% | $6.29 | $30,692 | +68.62% | |
| 2024-10-17 | Sale | KCK LTD. | 10 percent owner | 3,294 0.0111% | $6.28 | $20,686 | +70.42% | |
| 2024-10-16 | Sale | KCK LTD. | 10 percent owner | 6,900 0.0231% | $6.57 | $45,336 | +69.10% | |
| 2024-10-15 | Sale | KCK LTD. | 10 percent owner | 4,017 0.0133% | $6.50 | $26,098 | +68.58% | |
| 2024-10-14 | Sale | KCK LTD. | 10 percent owner | 4,031 0.0134% | $6.54 | $26,360 | +67.88% | |
| 2024-10-11 | Sale | KCK LTD. | 10 percent owner | 2,572 0.0083% | $6.35 | $16,320 | +64.45% | |
| 2024-10-10 | Sale | KCK LTD. | 10 percent owner | 2,504 0.0078% | $6.12 | $15,317 | +74.40% | |
| 2024-10-09 | Sale | KCK LTD. | 10 percent owner | 3,123 0.0097% | $6.10 | $19,065 | +77.25% | |
| 2024-10-08 | Sale | KCK LTD. | 10 percent owner | 6,000 0.0196% | $6.43 | $38,552 | +68.69% |
| Accelmed Partners II L.P. | director | 4432948 12.9149% | $54.57M | 3 | 0 | +120.72% |
| ORBIMED ADVISORS LLC | 10 percent owner | 3238199 9.4341% | $39.86M | 1 | 15 | <0.0001% |
| Norton Evan | director | 588235 1.7138% | $7.24M | 1 | 0 | <0.0001% |
| Fischer Frank M | director | 93291 0.2718% | $1.15M | 1 | 0 | <0.0001% |
| Ridley Irina | General Counsel and Secretary | 61139 0.1781% | $752,621.09 | 1 | 2 | <0.0001% |
| Garfield Greg Shaw | director | 38853 0.1132% | $478,280.43 | 1 | 0 | <0.0001% |
| Increased Positions | 64 | +78.05% | 3M | +12.32% |
| Decreased Positions | 38 | -46.34% | 2M | -7.46% |
| New Positions | 26 | New | 1M | New |
| Sold Out Positions | 7 | Sold Out | 478,842 | Sold Out |
| Total Postitions | 108 | +31.71% | 27M | +4.87% |
| Polar Capital Holdings Plc | $46,995.00 | 9.39% | 3.1M | +3M | New | 2025-09-30 |
| Soleus Capital Management, L.P. | $44,872.00 | 8.96% | 2.96M | +645,000 | +27.89% | 2025-09-30 |
| Orbimed Advisors Llc | $39,657.00 | 7.92% | 2.61M | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $38,626.00 | 7.72% | 2.55M | -38,865 | -1.5% | 2025-09-30 |
| Blackrock, Inc. | $36,661.00 | 7.32% | 2.42M | +97,487 | +4.2% | 2025-09-30 |
| Vanguard Group Inc | $21,782.00 | 4.35% | 1.44M | +66,574 | +4.86% | 2025-09-30 |
| First Light Asset Management, Llc | $20,632.00 | 4.12% | 1.36M | -20,339 | -1.47% | 2025-09-30 |
| Armistice Capital, Llc | $19,691.00 | 3.93% | 1.3M | +145,665 | +12.64% | 2025-09-30 |
| Kent Lake Pr Llc | $15,170.00 | 3.03% | 1M | +75,000 | +8.11% | 2025-09-30 |
| Driehaus Capital Management Llc | $14,253.00 | 2.85% | 939,519 | -65,839 | -6.55% | 2025-09-30 |